Rein Therapeutics logo
Rein Therapeutics
RNTX | NASDAQ
Chart Builder DCF Calculator
$0.40
-$0.15 (-27.55%)
At close: Nov 16, 2026, 4:00 PM ET
$0.38
-$0.02 (-5.35%)
After-hours: Nov 16, 2026, 7:30 PM ET

Rein Therapeutics Income Statement

Income statement explained
Fiscal Quarter
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
– – – – – – – – – – – – –
– – – – – – – – – – – – –
– – – – – – – – – – – – –
-6.08M -5.23M -3.96M -5.49M -6.87M -5.61M -5.8M -6.07M -9.04K -7.21K -7.29K -1.98K -1.99K
– – – – – – 700 – – – 600 – –
-6.38M -5.84M -32.68M -5.58M -6.82M -5.5M -42.53M -5.85M -8.94K -7.11K -7.34K -1.83K -1.79K
-6.38M -5.84M -31.97M -5.58M -6.82M -5.5M -40.98M -5.85M -8.94K -7.11K -7.34K -1.83K -1.79K
2.44M 2.16M 1.96M 3.81M 2.58M 2.56M 2.48M 2.35M 5.3K 3.74K 5.33K 1.96K 1.89K
3.64M 3.07M 2M 1.68M 4.29M 3.05M 3.32M 3.72M 3.74K 3.46K 1.97K 22 187
– – – – – – – – – – -12 6 -88
6.08M 5.23M 3.96M 5.49M 6.87M 5.61M 5.8M 6.07M 9.04K 7.21K 7.29K 1.98K 1.99K
– – – – – – – – – – – – –
– – – – – – – – – – – – –
6.08M 5.23M 3.96M 5.49M 6.87M 5.61M 5.8M 6.07M 9.04K 7.21K 7.29K 1.98K 1.99K
– – -712K – – – -1.54M – – – – – –
30.35M 30.35M 25.44M 26.36M 24.19M 22.94M 21.69M 21.66M 19.91M 8.3M 4.77M 4.54M 4.54M
30.35M 30.35M 25.44M 26.36M 24.19M 22.94M 21.69M 21.66M 19.91M 8.3M 4.77M 4.54M 4.54M
-0.21 -0.19 -1.22 -0.21 -0.28 -0.24 -1.89 -0.27 -0.45 -0.86 -1.54 -0.40 -0.39
-0.21 -0.19 -1.22 -0.21 -0.28 -0.24 -1.89 -0.27 -0.45 -0.86 -1.54 -0.40 -0.39
-6.38M -5.22M -3.87M -5.58M -6.82M -5.5M -42.53M -5.85M -4.94K 51.89K 44.7K 10.02K 9.92K
-6.38M -5.84M -3.87M -5.58M -6.82M -5.5M -42.53M -5.85M -8.94K -7.11K -7.3K -1.98K -2.08K
– 623K – – 1K – – – 4K 59K 52K 12K 12K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.